(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NOVOCHIZOL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

NOVOCHIZOL

ST13

US500000079289547

Class

1, 3, 5

Filing

79289547

Registration

6297647

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

03/24/2026

Trademark type

Word

Nice classes

1, 3, 5

Filing date

12/18/2019

Registration date

03/23/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/23/2021

Last transaction

03/24/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

CH

Examiner

JENKINS, KEISHA MONIQUE HARD

Law office

M30

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Novochizol SA
BOSTI Trading Ltd.

Representatives

Brian Tamsut SoCal IP Law Group LLP

Technical classification

Nice Classes

Class 1Class 3Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemical coating agents for medical devices; flocculants; chemicals for use in the purification of water; chemicals for use in separation and purification techniques; chemicals for use in chromatography; biochemical catalysts; tensio-active chemical agents and surface-active chemical agents for formulating poorly water-soluble substances; solubilizing agent for aerosols; chitosan for use as a raw ingredient in the manufacture of cosmetics or pharmaceuticals; preservatives for use in the pharmaceutical industry; chitosan-based polymers for use in the manufacture of pharmaceutical and cosmetic preparations; solubilizing agent for aerosol pharmaceutical preparations

Class 3

Non-medicated gelscreams and lotions for use against wrinkles and signs of aging; topical skin sprays for cosmetic purposes; cosmetic preparations for skin care; biopolymer-based non-medicated cosmetics and non-medicated toiletry preparations; biopolymer-based cosmeticsin particular non-medicated gelscreams and lotionsfor use against wrinkles and signs of aging; biopolymer-based topical skin sprays for cosmetic purposes; biopolymer-based cosmetic preparations for skin care

Class 5

Pharmaceutical and veterinary preparations for tissue repairjoint treatment and drug delivery; Pharmaceutical substances and preparations for healthcarefor tissue repairjoint treatment and drug delivery; pharmaceutical preparations for the treatment of eye diseases and conditions; eye drops; Medicated eye washcollyria; anti-infective preparations for veterinary purposes; biological implantsa vital processed human or animal connective tissue; surgical implants comprised of living tissues; biological tissue cultures for medical use; anti-protozoan agents; anti-inflammatory agents; drug delivery agentsdrug delivery agents in the form of powders or suspensions that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; diagnostic reagents and contrast media for medical purposes and use with imaging medical equipmentnamely X-ray tomographyNMR tomographyultrasound tomographyopticalluminescence and fluorescence tomographyEPR tomography and Terahertz tomography; Bandage material for dressings; Bandage material for hemostatic dressings; surgical and medical dressings; pre-filled syringes filled with medicinal products or fillers for medical purposes; injectable soft-tissue dermal fillersintra-articular fillers and intra-vascular fillers; bone void fillersintra-articular fillers and intra-vascular fillers comprised of living tissues; topical first aid gels for medical and therapeutic use

Publications

History of USPTO decisions and trademark events.

32 publications found

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

03/23/2026

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

07/24/2021

FICS

FINAL DISPOSITION NOTICE SENT TO IB

07/01/2021

FIMP

FINAL DISPOSITION PROCESSED

07/01/2021

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

06/23/2021

CHLD

CHANGE OF OWNER RECEIVED FROM IB

06/04/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

03/23/2021

GPNX

NOTIFICATION PROCESSED BY IB

01/11/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/05/2021

PUBO

PUBLISHED FOR OPPOSITION

01/05/2021

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

12/23/2020

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

12/23/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/16/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/02/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/10/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/09/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/09/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/04/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/04/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/04/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/04/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/04/2020

RFNT

REFUSAL PROCESSED BY IB

08/30/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

08/12/2020

RFRR

REFUSAL PROCESSED BY MPU

08/11/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

07/29/2020

CNRT

NON-FINAL ACTION WRITTEN

07/28/2020

MAFR

APPLICATION FILING RECEIPT MAILED

07/28/2020

DOCK

ASSIGNED TO EXAMINER

07/23/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/23/2020

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

07/21/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/16/2020

Continuous trademark protection

Get notified about every new filing that threatens NOVOCHIZOL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.